A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma

Diego Bagnasco(Ospedale Policlinico San Martino), Giorgio Walter Canonica(Humanitas University)
International Archives of Allergy and Immunology
January 1, 2016
10.1159/000447692
Cited by 215

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
|Allergy|2004|1.1k
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
|International Forum of Allergy & Rhinology|2018|549
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|428